Ixazomib Impurity 1 is a chemical compound used as a pharmaceutical intermediate in the manufacturing process of proteasome inhibitors. It is characterized by a complex polycyclic boronate ester structure with multiple stereocenters and aromatic substitution.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1201903-02-7
N,N',N''-((((1R,1'R,1''R)-(1,3,5,2,4,6-trioxatriborinane-2,4,6-triyl)tris(3-methylbutane-1,1-diyl))tris(azanediyl))tris(2-oxoethane-2,1-diyl))tris(2,5-dichlorobenzamide)
Pharmaceutical intermediate
Methyl 1H-indole-2-carboxylate
pharmaceutical intermediate
(3r,4s,5s)-tert-butyl 3-methoxy-5-methyl-4-(methylamino)heptanoate hydrochloride
Intermediate for Monomethyl auristatin E synthesis
5-Amino-1,3,4-thiadiazole-2-sulfonamide Hydrochloride Salt
Pharmaceutical intermediate for acetazolamide impurities
2,5-dichloro-N-[2-[[(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]butyl]amino]-2-oxoethyl]benzamide
CGUIBVMGUKXODV-OPKBTAHXSA-N
B1(O[C@@H]2C[C@@H]3C[C@H]([C@@]2(O1)C)C3(C)C)[C@H](CC(C)C)NC(=O)CNC(=O)C4=C(C=CC(=C4)Cl)Cl